en

PRODUCT DETAIL

Rydapt 25 mg mäkké kapsuly

Code 5606C
MA number EU/1/17/1218/001
Product Form: cps mol 112 (4x28)x25 mg (blis.PA/Al/PVC-Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX10 Midostaurin
Shelf life: 36
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 18.09.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.06.2022
eu-flag.png sk-flag.png